PAS
AMED

Point72 Asia (Singapore)’s Amedisys AMED Stock Holding History

Point72 Asia (Singapore)’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,553
Closed -$2.71M – 893
2025
Q2 		$2.71M Buy
27,553
+13,701
+99% +$1.3M 0.48% 51
2025
Q1 		$1.28M Buy
+13,852
New +$1.28M 0.34% 66
2024
Q2 		– Sell
-106
Closed -$9.73K – 1037
2024
Q1 		$9.73K Buy
+106
New +$9.93K ﹤0.01% 1005

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Point72 Asia (Singapore)'s AMED Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Amedisys (AMED) in Q3 2025, closing a stake of 27,553 shares — an estimated $2.71M sold.

Point72 Asia (Singapore) first reported a position in AMED in Q1 2024 and held it in 3 quarters. The position peaked at $2.71M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 27,553 Amedisys shares in Q3 2025, an estimated $2.71M.
  • Point72 Asia (Singapore) first reported a position in Amedisys in Q1 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s Amedisys position peaked at $2.71M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.